BENITEC BIOPHARMA INC. (BNTC) Free cash flow 2019–2025
BENITEC BIOPHARMA INC. (BNTC) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$23.6MFY2025 · since FY2019: $4.4M → -$23.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$23.6M | -20.5% |
| FY2024 | -$19.6M | -8.7% |
| FY2023 | -$18.0M | -13.2% |
| FY2022 | -$15.9M | -21.9% |
| FY2021 | -$13.1M | -71.1% |
| FY2020 | -$7.6M | -274.0% |
| FY2019 | $4.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice